Bridgebio Pharma Inc (BBIO)

Capital Expenditure

-$5.52M

TTM · Period ending: · USD

BBIO logo

BBIO Capital Expenditure

Latest reported-$5.52M
BBIO TTM CapEx (-$18.18M → -$5.52M)
High-resolution chart · PNG

BBIO capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bridgebio Pharma Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-5,515,000
-10,166,000
-11,692,000
-10,396,000
-11,658,000
-9,011,000
-8,908,000
-6,106,000
-4,805,000
-2,786,000
-1,306,000
-1,672,000
-2,000,000
-5,474,000
-6,321,000
-8,056,000
-48,759,000
-47,144,000
-48,246,000
-47,856,000
-6,943,000
-5,002,000
-7,518,000
-7,119,000
-6,951,000
-7,188,000
-5,138,000
-4,132,000
-4,356,000
-5,428,000
-18,178,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.